Perspective Therapeutics Files 8-K

Ticker: CATX · Form: 8-K · Filed: May 30, 2025 · CIK: 728387

Sentiment: neutral

Topics: regulatory-filing, corporate-update

TL;DR

Perspective Therapeutics (formerly Isoray) filed an 8-K on 5/30/25. No major news yet.

AI Summary

Perspective Therapeutics, Inc. filed an 8-K on May 30, 2025, reporting on other events and financial statements. The company, formerly known as Isoray, Inc., is incorporated in Delaware and headquartered in Seattle, Washington. This filing does not contain specific financial figures or details about the 'other events' reported.

Why It Matters

This 8-K filing indicates a regulatory update from Perspective Therapeutics, Inc., though specific operational or financial details are not immediately apparent from the provided text.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for reporting events and exhibits, with no immediate indication of significant financial distress or major corporate changes.

Key Players & Entities

FAQ

What specific 'Other Events' are being reported by Perspective Therapeutics, Inc. in this 8-K filing?

The provided text of the 8-K filing does not specify the details of the 'Other Events' beyond listing it as an item information category.

When was Perspective Therapeutics, Inc. previously known as Isoray, Inc.?

The filing indicates that the company's name changed from Isoray, Inc. on December 31, 2018.

What is the principal executive office address for Perspective Therapeutics, Inc.?

The principal executive offices are located at 2401 Elliott Avenue, Suite 320, Seattle, Washington, 98121.

What is the Commission File Number for Perspective Therapeutics, Inc.?

The Commission File Number for Perspective Therapeutics, Inc. is 001-33407.

What is the IRS Employer Identification Number (EIN) for Perspective Therapeutics, Inc.?

The IRS Employer Identification Number (EIN) for Perspective Therapeutics, Inc. is 41-1458152.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 30, 2025 regarding Perspective Therapeutics, Inc. (CATX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing